Dabur India Ltd (Dabur), the leading Indian FMCG company, is also a world leader in Ayurveda with a portfolio of over 250 Herbal/Ayurvedic products.
Valuations : We believe Dabur with its well-diversified product portfolio, leadership position & strong distribution reach is well placed to capitalize on recovery in rural demand. We maintain ‘BUY’ rating on the stock to BUY with a revised target price of Rs. 409 based on 40x FY20E EPS.
Research Report – Dabur India Ltd
Investments in equity shares, debentures, etc., are not obligations of, or guaranteed by Wealth India Financial Services Pvt. Ltd., and are subject to investment risks. Click here to read our full disclaimer.
Other articles you may like